Weiss RM - Search Results

1

A survivin gene signature predicts aggressive tumor behavior.

Salz W, Eisenberg D, Plescia J, Garlick DS, Weiss RM, Wu XR, Sun TT, Altieri DC. Salz W, et al. Among authors: weiss rm. Cancer Res. 2005 May 1;65(9):3531-4. doi: 10.1158/0008-5472.CAN-04-4284. Cancer Res. 2005. PMID: 15867343

2

Urine detection of survivin and diagnosis of bladder cancer.

Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC. Smith SD, et al. Among authors: weiss rm. JAMA. 2001 Jan 17;285(3):324-8. doi: 10.1001/jama.285.3.324. JAMA. 2001. PMID: 11176843

3

Bladder cancer detection with urinary survivin, an inhibitor of apoptosis.

Sharp JD, Hausladen DA, Maher MG, Wheeler MA, Altieri DC, Weiss RM. Sharp JD, et al. Among authors: weiss rm. Front Biosci. 2002 Feb 1;7:e36-41. doi: 10.2741/sharp. Front Biosci. 2002. PMID: 11815300 Review.

4

Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome.

Hausladen DA, Wheeler MA, Altieri DC, Colberg JW, Weiss RM. Hausladen DA, et al. Among authors: weiss rm. J Urol. 2003 Jul;170(1):230-4. doi: 10.1097/01.ju.0000063685.29339.24. J Urol. 2003. PMID: 12796695

5

Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer.

Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. Swana HS, et al. Among authors: weiss rm. N Engl J Med. 1999 Aug 5;341(6):452-3. doi: 10.1056/NEJM199908053410614. N Engl J Med. 1999. PMID: 10438269 No abstract available.

6

Downregulation of survivin is associated with reductions in TNF receptors' mRNA and protein and alterations in nuclear factor kappa B signaling in urothelial cancer cells.

Takizawa BT, Uchio EM, Cohen JJ, Wheeler MA, Weiss RM. Takizawa BT, et al. Among authors: weiss rm. Cancer Invest. 2007 Dec;25(8):678-84. doi: 10.1080/07357900701600954. Cancer Invest. 2007. PMID: 18058462

7

Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target.

Martin DT, Shen H, Steinbach-Rankins JM, Zhu X, Johnson KK, Syed J, Saltzman WM, Weiss RM. Martin DT, et al. Among authors: weiss rm. Mol Cancer Ther. 2019 Feb;18(2):413-420. doi: 10.1158/1535-7163.MCT-17-1079. Epub 2018 Oct 31. Mol Cancer Ther. 2019. PMID: 30381445 Free PMC article.

8

Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.

Martin DT, Steinbach JM, Liu J, Shimizu S, Kaimakliotis HZ, Wheeler MA, Hittelman AB, Mark Saltzman W, Weiss RM. Martin DT, et al. Among authors: weiss rm. Mol Cancer Ther. 2014 Jan;13(1):71-81. doi: 10.1158/1535-7163.MCT-13-0502. Epub 2013 Nov 12. Mol Cancer Ther. 2014. PMID: 24222663 Free PMC article.

9

Prostaglandin E2 production and cyclooxygenase-2 induction in human urinary tract infections and bladder cancer.

Wheeler MA, Hausladen DA, Yoon JH, Weiss RM. Wheeler MA, et al. Among authors: weiss rm. J Urol. 2002 Oct;168(4 Pt 1):1568-73. doi: 10.1016/S0022-5347(05)64522-3. J Urol. 2002. PMID: 12352459

10

Sertraline-induced 5-HT dysregulation in mouse cardiomyocytes and the impact on calcium handling.

Lu Y, Kenkel E, Zimmerman K, Weiss RM, Roghair RD, Haskell SE. Lu Y, et al. Among authors: weiss rm. Am J Physiol Heart Circ Physiol. 2024 Dec 1;327(6):H1559-H1576. doi: 10.1152/ajpheart.00692.2023. Epub 2024 Oct 18. Am J Physiol Heart Circ Physiol. 2024. PMID: 39423037 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters